Clinical Study
High Intensity Focused Ultrasound versus Brachytherapy for the Treatment of Localized Prostate Cancer: A Matched-Pair Analysis
Table 5
Comparison of overall complications by grade of severity between the two groups.
| ā | Grade 1 | Grade 2 | Grade 3a | Grade 3b | ā | HIFU | BT | HIFU | BT | HIFU | BT | HIFU | BT |
| LUTS/hematuria (early) | 23/70 (32.9%) | 18/59 (30.5%) | 5/70 (7.1%) | 7/59 (11.9%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | LUTS/hematuria (late) | 3/69 (4.3%) | 2/53 (3.8%) | 16/69 (23.2%) | 11/53 (20.7%) | 0 (0%) | 1/53 (1.9%) | 0 (0%) | 0 (0%) | Urinary tract infection | 0 (0%) | 0 (0%) | 15/70 (21.4%) | 5/59 (8.5%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | Acute urinary retention | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 14/70 (20.0%) | 4/59 (6.8%) | 2/70 (2.8%) | 0 (0%) | Urinary stricture | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 2/69 (2.9%) | 0 (0%) | 15/69 (21.7%) | 2/53 (3.8%) | Urinary incontinence | 5/69 (7.2%) | 1/53 (1.9%) | 0 (0%) | 1/53 (1.9%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | Gastrointestinal toxicities | 0 (0%) | 0 (0%) | 0 (0%) | 1/59 (1.7%) | 0 (0%) | 0 (0%) | 1/70 (1.4%) | 1/59 (1.7%) |
|
|